Both in Biotechnology
BioCardia vs Scilex Holding
Over the past year BCDA returned −31.3% and SCLX returned −90.7%; their daily moves had a correlation of 0.02.
BCDA −31.3% SCLX −90.7%Growth of $1, one year, split-adjusted
| Metric | BCDA | SCLX |
|---|---|---|
| Price | $0.9131 | $1.83 |
| Market cap | $13.8M | $12.9M |
| Today | −0.92% | −1.08% |
| 1 month | −13.9% | −53.8% |
| 6 months | −17.7% | −80.7% |
| Year to date | −27.0% | −85.0% |
| 1 year | −34.3% | −89.8% |
| Revenue growth (YoY) | — | −22.8% |
| Gross margin | — | 51.9% |
| Net margin | — | −1501.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.4× |
| Net cash | $4.1M | -$82.5M |
| Dividend yield | — | — |
| Volatility (60d) | 68.9% | 70.2% |
| Short % of float | 6.2% | 2.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).